GENB - Company ID 0002100782
As of 2026-09-07, Generate Biomedicines, Inc. (GENB) has a market capitalization of $2.10 B, making it the #2110 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $2.10 B |
| 2026-09-06 | $2.10 B |
| 2026-09-05 | $2.10 B |
| 2026-09-04 | $2.10 B |
| 2026-09-03 | $2.09 B |
| 2026-09-02 | $2.09 B |
| 2026-09-01 | $2.03 B |
| 2026-08-31 | $1.96 B |
| 2026-08-30 | $1.97 B |
| 2026-08-29 | $1.97 B |
| 2026-08-28 | $1.97 B |
| 2026-08-27 | $2.02 B |
As of 2026-09-07, Generate Biomedicines, Inc. (GENB) has a market capitalization of $2.10 B, making it the #2110 most valuable US-listed company.
Generate Biomedicines, Inc. is the #2110 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $2.09 B |
| 2026-08-25 | $2.61 B |
| 2026-08-24 | $2.25 B |
| 2026-08-23 | $2.07 B |
| 2026-08-22 | $2.07 B |
| 2026-08-21 | $2.07 B |
| 2026-08-20 | $2.04 B |
| 2026-08-19 | $2.18 B |
| 2026-08-18 | $2.06 B |
| 2026-08-17 | $1.99 B |
| 2026-08-16 | $2.00 B |
| 2026-08-15 | $2.00 B |
| 2026-08-14 | $2.00 B |
| 2026-08-13 | $1.92 B |
| 2026-08-12 | $1.93 B |
| 2026-08-11 | $1.83 B |
| 2026-08-10 | $1.89 B |
| 2026-08-09 | $1.84 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.